Nahdi Medical Company (TADAWUL:4164)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
93.00
+2.30 (2.54%)
Nov 5, 2026, 3:19 PM AST

Nahdi Medical Company Cash Flow Statement

Millions SAR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
798.6830.74820.72892.62887.81812.53
Depreciation & Amortization
817.23763.17675.92594.95575.75550.48
Other Amortization
0.0431.5327.5223.1320.8921.02
Loss (Gain) From Sale of Assets
-0.86-0.49-1.54-0.2217.42-0.03
Asset Writedown & Restructuring Costs
---1.6-0.5-10.11-19.49
Provision & Write-off of Bad Debts
1.822.69-0.19-4.493.195.87
Other Operating Activities
57.6731.04-18.16-46.46120.43-23.01
Change in Accounts Receivable
-188.22-128.6237.54-38.166.89-47.65
Change in Inventory
4.25-628.34-333.74-214.62-127.0185.85
Change in Accounts Payable
-144.1170.05338.32257.14153.1743.74
Change in Other Net Operating Assets
195.4561.95-53.44-147.3719.44-95.34
Operating Cash Flow
1,5291,1341,4911,3161,6681,334
Operating Cash Flow Growth
8.95%-23.98%13.32%-21.09%25.03%-15.88%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-290.13-387.09-339.53-353.86-250.27-282.57
Sale of Property, Plant & Equipment
0.640.491.570.250.17.1
Sale (Purchase) of Intangibles
-30.52-30.53-44.97-30.65-24.97-23.89
Investment in Securities
-541.68-----
Other Investing Activities
39.0162.854.9252.7--
Investing Cash Flow
-822.68-354.33-328.01-331.56-275.13-299.36

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--453.96-401.96-435.67-416.96-382.07
Lease Payments
-456.45-453.96-401.96-435.67-416.96-382.07
Total Debt Repaid
-456.45-453.96-401.96-435.67-416.96-382.07
Net Debt Issued (Repaid)
-456.45-453.96-401.96-435.67-416.96-382.07
Common Dividends Paid
-728-728-715-715-300.3-1,260
Financing Cash Flow
-1,184-1,182-1,117-1,151-717.26-1,642

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.150.190.77-0.45-0.21-0.02
Net Cash Flow
-477.61-402.3747.15-166.65675.27-607.49

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,239746.641,152962.171,4181,051
Free Cash Flow Growth
23.53%-35.18%19.71%-32.13%34.83%-18.50%
Free Cash Flow Margin
11.53%7.31%12.19%11.04%16.45%13.04%
Free Cash Flow Per Share
9.535.748.867.4010.908.09
Levered Free Cash Flow
932.33397.98814.89645.71,040712.08
Unlevered Free Cash Flow
986.75452.98860.96677.231,071761.38
Free Cash Flow After Leases
782.8292.69749.86526.491,001669.33

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-141.86115.8750.4679.3878.88
Change in Working Capital
-132.62-524.96-11.32-14352.49-13.4